Cargando…
Frontalis suspension surgery to treat patients with essential blepharospasm and apraxia of eyelid opening-technique and results
INTRODUCTION: We describe the results of 15 patients suffering from essential blepharospasm with apraxia of eyelid opening who underwent frontalis suspension surgery. MATERIAL AND METHODS: Patients with apraxia of eyelid opening and unresponsive to botulinum toxin injections were studied. Bilateral...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213496/ https://www.ncbi.nlm.nih.gov/pubmed/25338619 http://dx.doi.org/10.1186/1746-160X-10-44 |
_version_ | 1782341827454566400 |
---|---|
author | Karapantzou, Chrisanthi Dressler, Dirk Rohrbach, Saskia Laskawi, Rainer |
author_facet | Karapantzou, Chrisanthi Dressler, Dirk Rohrbach, Saskia Laskawi, Rainer |
author_sort | Karapantzou, Chrisanthi |
collection | PubMed |
description | INTRODUCTION: We describe the results of 15 patients suffering from essential blepharospasm with apraxia of eyelid opening who underwent frontalis suspension surgery. MATERIAL AND METHODS: Patients with apraxia of eyelid opening and unresponsive to botulinum toxin injections were studied. Bilateral frontalis suspension surgery was performed (sling operation) using polytetrafluoroethylene (Gore-Tex®) sutures. The patients reported the degree of improvement using a subjective rating scale to evaluate the benefit of the operation at two times after surgery (0-10 days and 180-360 days). RESULTS: The patients reported a high degree of subjective improvement. In the early postoperative period (0-10 days) the mean degree of subjective improvement was 74.6% (standard deviation (SD) 26.4%). At 180-360 days after surgery the mean improvement was 70.0% (SD 26.7%). Small hematomas of the upper lid occurred postoperatively in all patients. Other complications were suture extrusions (9.1%), suture granulomas (6.1%), lacrimation (5.0%) and local infections (7.5%). Postoperatively, all patients needed additional botulinum toxin injections for optimal outcome. CONCLUSION: Frontalis suspension surgery is a minimally invasive and effective treatment option for apraxia of eyelid opening in patients with essential blepharospasm unresponsive to botulinum toxin injections alone. |
format | Online Article Text |
id | pubmed-4213496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42134962014-10-31 Frontalis suspension surgery to treat patients with essential blepharospasm and apraxia of eyelid opening-technique and results Karapantzou, Chrisanthi Dressler, Dirk Rohrbach, Saskia Laskawi, Rainer Head Face Med Research INTRODUCTION: We describe the results of 15 patients suffering from essential blepharospasm with apraxia of eyelid opening who underwent frontalis suspension surgery. MATERIAL AND METHODS: Patients with apraxia of eyelid opening and unresponsive to botulinum toxin injections were studied. Bilateral frontalis suspension surgery was performed (sling operation) using polytetrafluoroethylene (Gore-Tex®) sutures. The patients reported the degree of improvement using a subjective rating scale to evaluate the benefit of the operation at two times after surgery (0-10 days and 180-360 days). RESULTS: The patients reported a high degree of subjective improvement. In the early postoperative period (0-10 days) the mean degree of subjective improvement was 74.6% (standard deviation (SD) 26.4%). At 180-360 days after surgery the mean improvement was 70.0% (SD 26.7%). Small hematomas of the upper lid occurred postoperatively in all patients. Other complications were suture extrusions (9.1%), suture granulomas (6.1%), lacrimation (5.0%) and local infections (7.5%). Postoperatively, all patients needed additional botulinum toxin injections for optimal outcome. CONCLUSION: Frontalis suspension surgery is a minimally invasive and effective treatment option for apraxia of eyelid opening in patients with essential blepharospasm unresponsive to botulinum toxin injections alone. BioMed Central 2014-10-22 /pmc/articles/PMC4213496/ /pubmed/25338619 http://dx.doi.org/10.1186/1746-160X-10-44 Text en © Karapantzou et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Karapantzou, Chrisanthi Dressler, Dirk Rohrbach, Saskia Laskawi, Rainer Frontalis suspension surgery to treat patients with essential blepharospasm and apraxia of eyelid opening-technique and results |
title | Frontalis suspension surgery to treat patients with essential blepharospasm and apraxia of eyelid opening-technique and results |
title_full | Frontalis suspension surgery to treat patients with essential blepharospasm and apraxia of eyelid opening-technique and results |
title_fullStr | Frontalis suspension surgery to treat patients with essential blepharospasm and apraxia of eyelid opening-technique and results |
title_full_unstemmed | Frontalis suspension surgery to treat patients with essential blepharospasm and apraxia of eyelid opening-technique and results |
title_short | Frontalis suspension surgery to treat patients with essential blepharospasm and apraxia of eyelid opening-technique and results |
title_sort | frontalis suspension surgery to treat patients with essential blepharospasm and apraxia of eyelid opening-technique and results |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213496/ https://www.ncbi.nlm.nih.gov/pubmed/25338619 http://dx.doi.org/10.1186/1746-160X-10-44 |
work_keys_str_mv | AT karapantzouchrisanthi frontalissuspensionsurgerytotreatpatientswithessentialblepharospasmandapraxiaofeyelidopeningtechniqueandresults AT dresslerdirk frontalissuspensionsurgerytotreatpatientswithessentialblepharospasmandapraxiaofeyelidopeningtechniqueandresults AT rohrbachsaskia frontalissuspensionsurgerytotreatpatientswithessentialblepharospasmandapraxiaofeyelidopeningtechniqueandresults AT laskawirainer frontalissuspensionsurgerytotreatpatientswithessentialblepharospasmandapraxiaofeyelidopeningtechniqueandresults |